{"title":"中国新冠肺炎统计数据有什么问题?","authors":"I. Nesteruk","doi":"10.54103/2282-0930/20637","DOIUrl":null,"url":null,"abstract":"The media is reporting tens of millions of new daily Covid-19 cases in China in the final days of 2022. However, official statistics have recorded in mainland China only 1.9 million cases since the start of the pandemic and stopped providing data after December 21, 2022. Results of SIR simulations showed that daily numbers of new cases stated to decline in December 2022. The contradictions in statistics and estimations are discussed. Millions of new daily cases in China look very unlikely.","PeriodicalId":45811,"journal":{"name":"Epidemiology Biostatistics and Public Health","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"What is wrong with Chinese COVID-19 statistics?\",\"authors\":\"I. Nesteruk\",\"doi\":\"10.54103/2282-0930/20637\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The media is reporting tens of millions of new daily Covid-19 cases in China in the final days of 2022. However, official statistics have recorded in mainland China only 1.9 million cases since the start of the pandemic and stopped providing data after December 21, 2022. Results of SIR simulations showed that daily numbers of new cases stated to decline in December 2022. The contradictions in statistics and estimations are discussed. Millions of new daily cases in China look very unlikely.\",\"PeriodicalId\":45811,\"journal\":{\"name\":\"Epidemiology Biostatistics and Public Health\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Epidemiology Biostatistics and Public Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.54103/2282-0930/20637\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epidemiology Biostatistics and Public Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54103/2282-0930/20637","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Nursing","Score":null,"Total":0}
The media is reporting tens of millions of new daily Covid-19 cases in China in the final days of 2022. However, official statistics have recorded in mainland China only 1.9 million cases since the start of the pandemic and stopped providing data after December 21, 2022. Results of SIR simulations showed that daily numbers of new cases stated to decline in December 2022. The contradictions in statistics and estimations are discussed. Millions of new daily cases in China look very unlikely.
期刊介绍:
Epidemiology, Biostatistics, and Public Health (EBPH) is a multidisciplinary journal that has two broad aims: -To support the international public health community with publications on health service research, health care management, health policy, and health economics. -To strengthen the evidences on effective preventive interventions. -To advance public health methods, including biostatistics and epidemiology. EBPH welcomes submissions on all public health issues (including topics like eHealth, big data, personalized prevention, epidemiology and risk factors of chronic and infectious diseases); on basic and applied research in epidemiology; and in biostatistics methodology. Primary studies, systematic reviews, and meta-analyses are all welcome, as are research protocols for observational and experimental studies. EBPH aims to be a cross-discipline, international forum for scientific integration and evidence-based policymaking, combining the methodological aspects of epidemiology, biostatistics, and public health research with their practical applications.